logo
UK slides down women's health rankings for fourth year in a row

UK slides down women's health rankings for fourth year in a row

Times26-06-2025
The UK has dropped down a worldwide women's health league for the fourth consecutive year, as countries such as Lithuania, Kazakhstan and Saudi Arabia perform better.
Experts described the change as 'alarming' and 'unacceptable', as it was also revealed women in the UK were more likely to experience poor emotional health and chronic pain than the EU average.
There has been a year-on-year decline in how women in the UK rate their pregnancy care, and they were less likely to be screened for conditions such as diabetes, high blood pressure and cancer than in comparable countries, the global study found.
The UK now ranks at just 41 out of 142 countries in the Hologic Global Women's Health Index, down from 37 last year and 30 in 2023. The annual league table is based on surveys of more than 78,000 women globally. The UK is also below the US, where women's healthcare has been hit by restrictions on access to abortion in many states.
The report found women living in the UK were now more likely to experience negative feelings such as sadness, stress and anger than they were in 2020 during the pandemic, with 39 per cent saying they felt 'worry'.
The number of women in the UK who thought their pregnancy care was 'high quality' has also dropped every year since the survey began, falling from 79 per cent four years ago to 72 per cent in this year's report.
• Hilary Rose: Gynaecology is seen as a lifestyle medicine — women are being betrayed
And a record 29 per cent of UK women said they experienced daily physical pain, up from 24 per cent four years ago. More than 25 per cent said they were limited in daily activities by ongoing health issues.
Janet Lindsay, the chief executive of the charity Wellbeing of Women, said: 'These figures are unacceptable for one of the world's wealthier nations and reflect long-standing underinvestment in women's health.
'Women's health should not be treated as an afterthought. It requires sustained political leadership, better access to care, increased research funding, and a shift in culture that truly values and listens to women.'
Lindsay called for women's health to be put at 'the heart of our national agenda' in the government's forthcoming ten-year plan for the NHS.
• NHS drops dementia and women's health targets to end 'overspending'
Researchers blamed the rankings slide on the UK's failure to act to improve women's healthcare since the pandemic, despite the creation of a women's health strategy.
'While the women's health strategy, now nearly three years in, has delivered some progress, it is yet to deliver significant impact,' the report's authors said. 'The latest data exposes a widening gap between policy ambition and the everyday experiences of women.'
Professor Ranee Thakar, president of the Royal College of Obstetricians and Gynaecologists, added: 'Too often, systemic, operational, structural and cultural issues mean women do not get the care they deserve. The government's ten-year health plan offers a vital opportunity to change this.'
For the index, each country was assigned a score based on its performance in five areas of women's health and wellbeing: preventive care (such as screening for cancer and high blood pressure); basic needs (including ease of access to food and housing); health and safety (including how safe women feel walking at night and the quality of pregnancy care); individual health (including how pain affects women's daily lives); and emotional health.
The UK scored 59 out of 100, putting it below the EU average of 60 and on a par with Iceland, Bulgaria and France.
Although the UK ranked in the top third of countries worldwide, it was in the bottom third in Europe, placed at just 23 out of 31 European countries.
Other countries have made progress and moved ahead. Slovenia, for example, was ranked at 27 out of 31 European countries last year, but has now edged in front of the UK into 19th place.
'This is a four-year decline that no one can ignore,' said Tim Simpson, a senior director at Hologic. 'Women's health must remain a national priority, yet this data shows we are losing ground.'
The top-ranked countries globally were Taiwan (68), Kuwait (67), Austria (66), Switzerland (65) and Finland (65).
• Women left in pain by healthcare no better than Kosovo, poll finds
Other countries which outperformed the UK included Bahrain, which was eighth overall with a score of 64, Kazakhstan (13th with a score of 63), Saudi Arabia (14th with a score of 63), Slovenia (31st with a score of 60) and Kosovo (35th with a score of 60).
New Zealand was ranked at 37th and the USA at 38th, both with a score of 60, while Australia dropped to 43rd place, with a score of 59.
The worst countries for women's health were Afghanistan, with a score of 30, followed by the Democratic Republic of the Congo (34), Chad (35), Sierra Leone (36) and Liberia (37). Globally, the average score was 53.
This year's index was compiled based on data obtained from interviews carried out in 2023 with around 500 women in each country by the global analytics firm Gallup and Hologic, a medical technology company specialising in women's health.
A Department of Health and Social Care spokesman said that the previous government was in power at the time the surveys for the report were carried out.
'Women have been let down by a health service which was not focused on their needs, which is why we are on a mission to get the NHS working for women,' the spokesman added. 'Equality will be at the heart of our ten-year health plan to fix the NHS.
'We're making progress, including adding 4.2 million extra appointments, tackling gynaecology waiting lists using the private sector, trialling AI for breast cancer screening, and from October this year, making emergency hormonal contraception free in pharmacies.
'There's still more to do, and we are committed to turning commitments into tangible action.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Hunger-driven A&E admissions spiral amid cost-of-living crisis
Hunger-driven A&E admissions spiral amid cost-of-living crisis

The Independent

time3 minutes ago

  • The Independent

Hunger-driven A&E admissions spiral amid cost-of-living crisis

Hungry patients are overwhelming NHS emergency departments at unprecedented levels, researchers claim. Admissions to hospital Accident and Emergency (A&E) units because of hunger have more than tripled, rising by nearly 219 per cent in five years, figures suggest. Analysis of NHS data shows a lack of food was the fastest growing cause of A&E admissions in England between 2018-19 and 2023-24, as food prices and poverty spiralled. As the cost-of-living crisis gripped the UK, experts repeatedly warned that households were being plunged into poverty, with food bank use soaring and charities finding parents going hungry so their children could eat. Health experts warned in 2022 that millions of people were facing a 'significant humanitarian crisis', exacerbated by rocketing fuel bills. In 2018-19, 70 patients needed emergency care for hunger, the statistics show, but the figure shot up to 230 after five years – a 218.5 per cent increase. Paula Lingard, of the ID Band Company, which analysed the NHS data, said: 'The significant rise in admissions related to lack of food is particularly concerning and may reflect growing food insecurity in England, highlighting the importance of addressing basic needs as part of our approach to public health.' Recently, the Resolution Foundation think tank said the outlook for living standards for UK households remains bleak for the rest of the 2020s, which it said could become 'the first decade of the modern era to witness no improvement in disposable incomes across Britain'. Household debts have continued to rise since last year. The biggest actual increase in A&E admission numbers over the five years was down to adverse reactions to standard medical procedures. Cases rose from 40,881 to 103,295 over the five years – a 144.9 per cent increase. Environmental pollution-related illnesses caused the second-biggest proportionate rise in admissions, increasing by 191 per cent in five years. Patient numbers tripled from 16 to 48. Surgical errors drove the third-highest percentage jump, with emergency figures rising 179.9 per cent. NHS records show 4,094 patients needed urgent treatment after medical mishaps in 2023-24, against 1,418 in 2018-19. Cardiovascular equipment problems more than doubled, from 325 to 775. But cases of self-harm fell, with deliberate drug overdoses dropping by nearly half between 2018 and 2024, from 12,298 to 6,499. Shotgun and rifle assault injuries dropped from 56 in 2018-19 to just 17. The Independent has approached the Department for Health and Social Care for comment.

The common antibiotic that could leave you wheelchair-bound
The common antibiotic that could leave you wheelchair-bound

Telegraph

time4 minutes ago

  • Telegraph

The common antibiotic that could leave you wheelchair-bound

Fluoroquinolones are amongst the most commonly-prescribed antibiotics in the UK, often dispensed for ailments ranging from urinary tract infections to respiratory issues. Prescribed regularly, they are seen by many healthcare professionals as a quick fix for a variety of bacterial infections. But for some patients, the consequences of these medications are nothing short of devastating, leaving them with lifelong disability, wheelchair-bound and, in some cases, even thoughts of suicide. I know this first hand. I'm Nathan Kay, a journalist and editor. I've worked for publications such as The Mail on Sunday, Daily Express and CNN, covering everything from royal news to celebrity gossip. I was a regular 40-something-year-old, living in the city, healthy and active, swimming and gyming regularly, working in a high-stress job. I had a career I loved and a life I was proud of. That was until the day I took an antibiotic that I thought was nothing more than a routine prescription – Ciprofloxacin, a common fluoroquinolone. What followed was a descent into chronic pain, brain fog, and fatigue that I couldn't shake. My life, my career and my relationships were completely altered by an antibiotic more powerful than I could ever have imagined. I am one of the thousands affected by what's known as fluoroquinolone toxicity, or 'being floxed.' It's a term used by patients who have suffered severe, sometimes permanent side effects from these antibiotics. And it's growing. Studies show that fluoroquinolones are prescribed more than 20,000 times a month in the UK, and while the majority of people experience no lasting effects, an alarming number of others, like me, find their lives permanently altered. A significant portion of those affected by fluoroquinolone toxicity, as many as 15 per cent (according to some estimates), experience debilitating symptoms that can persist long after the drug is discontinued, with some patients struggling to find effective treatment. The psychological toll is often ignored, yet research shows a strong correlation between fluoroquinolone use and mental health issues, including depression and suicide. GPs are essentially playing Russian roulette with patient health by prescribing these drugs without fully acknowledging or preparing patients for the life-altering risks they may face. This article aims to highlight the growing problem, with first-hand accounts from patients whose lives have been destroyed by these antibiotics, supported by expert opinions and statistics showing just how many lives are being impacted. The growing issue: What are fluoroquinolones? Fluoroquinolones are a class of broad-spectrum antibiotics often used to treat a variety of bacterial infections. They include well-known medications such as Ciprofloxacin, Levofloxacin, and Moxifloxacin, and are highly effective, able to penetrate different areas of the body to fight infections in the bladder, lungs and skin, among others. Their strength makes them invaluable for certain serious infections – but also potentially dangerous. Professor Munir Pirmohamed, 62, a consultant physician at the Royal Liverpool Hospital and leading pharmacogenetics expert at the University of Liverpool, explains: 'They interfere with the normal functioning of the bacterial cell by inhibiting two main enzymes, DNA gyrase and Topoisomerase IV. The bacteria cannot repair their DNA, and this kills the bacterial cells.' From the start, he notes, it has been known that they can cause tendon problems, most often with the Achilles. But the damage can go further: 'There is concern about FQAD [Fluoroquinolone-Associated Disability]. In some people, FQAD represents a life-changing event. The severity, recovery and prognosis vary. There are many theories why these drugs cause the problem, including effects on mitochondria and on the immune system, but none have been proven.' Though fluoroquinolones are prescribed regularly, the risk associated with them is often underestimated. In 2024, the MHRA (Medicines and Healthcare products Regulatory Agency) issued updated guidelines advising that these antibiotics should only be prescribed when other first-line treatments are unsuitable or ineffective. Despite this, there are still over 20,000 prescriptions written for Ciprofloxacin each month in the UK alone. The concerns: The dark side of Fluoroquinolones Fluoroquinolones have been linked to devastating side effects, leaving many patients disabled and in a state of constant suffering. The impact can be profound, with some experiencing chronic pain, fatigue and neurological disorders, all of which can dramatically alter quality of life. For some, the consequences are so severe that they lead to thoughts of suicide. The concern with fluoroquinolones isn't just that they have the potential to cause discomfort – the risks can be life-altering. For 49-year-old recruitment consultant Victoria Abotorabi from Leeds, the consequences were devastating when, in 2024, she was prescribed Ciprofloxacin with prednisolone for a suspected sinus infection. 'The out-of-hours ENT didn't make me aware of the potential side effects – neither did the pharmacy.' Five days in she had pins and needles, and numb arms and hands. A&E checked her heart but not her medication. Two weeks later, she woke with severe head pain and pressure. Tests followed – an MRI and lumbar puncture – but still no review of her antibiotics. At one point, she recalls, 'every single muscle in my body went into spasm.' Victoria's symptoms escalated to the point where she became housebound, and unable to work or care for her children. 'This has completely devastated my life,' she says. 'I have lost my physical and mental health. I have severe PTSD, depression, chronic pain and a diagnosis of fibromyalgia, dysautonomia, FND and digestive issues… A year later, I am still struggling.' She has been referred to a mental health crisis team after suicidal thoughts. 'I couldn't stop crying… I was in so much pain and so scared I was dying, and no one could help me. I tried to end my life because I was in so much physical pain. I have never thought about suicide before.' The psychiatric risks are stark. In one high-profile case, respected cardiologist Dr Robert Stevenson died by suicide shortly after starting Ciprofloxacin. A coroner concluded the drug's psychiatric effects – including depression and suicidal thoughts – contributed to his death. The science behind the damage Dr Richard Berwick, 36, consultant in pain medicine at the Walton Centre and a Versus Arthritis clinical training fellow at the University of Liverpool, explains one theory as to why fluoroquinolones may be particularly harmful because of their ability to damage cells at the mitochondrial level. 'During an FQ toxicity reaction, cell mitochondria (the cell powerhouse) might be disrupted, causing cells to become injured, especially nerves and muscles. They can also block nerve channels leading to altered brain function,' he explains. This disruption can lead to long-term symptoms that continue long after the medication is stopped. As Dr Thuva Amuthan, 34, a general practitioner, further elaborates: 'Even a short course can, in rare cases, lead to long-term problems with tendons, muscles, joints, nerves and sometimes mood and memory. Early recognition of symptoms is vital.' The people suffering from a lifelong struggle For me, fluoroquinolone toxicity left me virtually bedridden for six months, unable to move and feeling poisoned. I've improved to about 80 per cent of my previous health, but never fully recovered. At the same time, a quad bike accident left me with multiple fractures, compounding my ongoing pain. Outwardly, I may look fine, but daily fatigue and discomfort remain constant companions. For Myles Washington, 38, a former personal trainer from the Isle of Wight, the ordeal began at 14, when he was given a fluoroquinolone for what was likely an allergy. At 24, he was prescribed another course for a misdiagnosed condition. 'It completely destroyed my health and changed the course of my life,' he says. 'I lost my career, my dreams and my identity.' He has since endured torn ligaments, chronic fatigue, tendon ruptures and nerve symptoms. 'This isn't just a temporary side effect,' he says. 'It's long-term, progressive damage.' Jeremy Maddock, 57, who runs an architectural practice in Devon, was floxed after taking Ciprofloxacin for a presumed infection. The side effects left him crawling upstairs and barely able to walk. 'The pain has moved around nearly every part of my body. I suffered psychological stress and suicidal ideation way beyond the normal realms of anxiety.' Years later he lives more normally, but must take extreme care to avoid relapse. He credits the Fluoroquinolone Toxicity Support UK Facebook group with 'probably saving lives.' Treatment – or the lack of it There is no standard treatment protocol for fluoroquinolone toxicity. Dr Berwick says supportive care is key, with therapies to help people live better despite symptoms. Some may use anti-neuropathic painkillers, though these bring their own side effects. Only one specialist in England can formally diagnose the condition. Many patients, says Fluoroquinolone Toxicity Support UK Facebook group co-founder Miriam Knight, 73, are steered towards expensive, unproven alternative therapies. 'Steer very well clear,' she advises. 'There are absolutely no guarantees except that the clinic will make money.' Professor Pirmohamed agrees, adding that: 'Many people are being offered untested and untried treatments, which can be expensive and potentially dangerous. I am not convinced there is enough evidence to recommend them.' I've tried B12 injections and quarterly vitamin-and-magnesium IV treatments myself. They help briefly, but offer no long-term fix. What's next? The road to change Research is underway, but funding is scarce. Professor Pirmohamed calls for dedicated investment to define the condition, identify genetic risk factors and develop diagnostic tests and treatments – all with strong patient involvement. I took part in the APIF study into autoimmune phenotyping in fibromyalgia, run by the University of Liverpool and The Walton Centre NHS University Hospital. Dr Berwick explains that he observed two fluoroquinolone toxicity patients in the study had temperature sensitivity, which is often seen in fibromyalgia. He noticed that the participants who develop fibromyalgia-type syndromes after fluoroquinolones report heightened cold sensitivity, and cold exposure can exacerbate pain. It's a link that suggests there could be an affected sensory-nerve or central-sensitisation pathway in fluoroquinolone toxicity patients, and researchers are now actively investigating that. Genetics may also play a role, making some people inherently more prone to long-term reactions. What can you do? If prescribed a fluoroquinolone, ask about alternatives. Ensure your doctor knows of any conditions that may make you more vulnerable. When you're offered a fluoroquinolone, ask your GP whether safer first-line antibiotics are suitable – and check for red-flag risk factors if you're aged over 60, suffer from renal impairment, have been diagnosed with fibromyalgia, suffer from autoimmune diseases, have a history of tendon problems or have had an organ transplant. These groups face higher odds of serious side effects. If you take a fluoroquinolone, report any tendon pain, weakness, dizziness or mood changes immediately. For those already affected, community support is vital. Miriam Knight's group, founded in 2015, offers a lifeline to sufferers, reassuring them they are not alone or 'going mad.' Members share advice and comfort, without giving direct medical recommendations.

Teen vaping a gateway to smoking, study suggests
Teen vaping a gateway to smoking, study suggests

BBC News

time34 minutes ago

  • BBC News

Teen vaping a gateway to smoking, study suggests

Children who vape are more likely to go on to be smokers, be diagnosed with asthma and have poor mental health, according to new of York experts partnered with the London School of Hygiene and Tropical Medicine for the study, said to be the largest global review on vaping in young found "consistent evidence" that young people who vaped were three times more likely to become smokers, with an increased risk of respiratory illness and substance Su Golder, associate professor in health science at York, called for marketing restrictions, saying: "Anything that could reduce the uptake of vaping in young people would be welcomed." Experts analysed all available reviews on youth vaping, which included 56 reviews on 384 of these looked at the use of e-cigarettes among young people and later cigarette data suggested an increased risk among young people who vaped of developing asthma or asthma exacerbation, with other outcomes including pneumonia, bronchitis, lower total sperm counts, dizziness, headaches and was also a link identified between depression and suicidal thoughts among young Golder said the "consistency in the evidence is striking". She said: "Across multiple studies, young people who use e-cigarettes are more likely to smoke in the future."These findings support stronger public health measures to protect teens from the risks associated with vaping."Dr Golder suggested increased regulation of vaping, "particularly restrictions on marketing that's aimed at young people and not at the smoking sensation side of things".Commenting on the study, Jamie Strachan, operations director at vape retailer VPZ, said: "Vaping is intended solely for existing adult smokers as a less harmful alternative to combustible tobacco."It should never be marketed to, sold to, or used by children and non-smokers."Dr James Murphy from British American Tobacco said that "enforcing high standards and preventing under-age use is vital to achieving the UK's smoke-free goal". Listen to highlights from North Yorkshire on BBC Sounds, catch up with the latest episode of Look North.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store